According to analysts at Zion Market Research, the global neurological biomarkers market was valued at USD 6,371.69 million in 2019 and is expected to exhibit a CAGR of 14.5% during the forecast period (2020–2026). The surging incidence of neurological diseases and augmenting prominence on early identification & treatment are likely to propel the growth of market. The high occurrence of neurological disorders is a prime driving factor for this market. According to the WHO estimates issued in 2018, more than 300 million people of all ages experience clinical depression globally. In addition, the lack of competent diagnostics in undeveloped and developing countries might augment the mortality rate of neurological disorders.
Some of the leading players in the market are QIAGEN; Abbott; Thermo Fisher Scientific Inc.; Myriad RBM; Bio-Rad Laboratories, Inc.; Athena Diagnostics; Acumen Pharmaceuticals; AbaStar MDx, Inc.; Alseres Pharmaceuticals, Inc.; and BANYAN BIOMARKERS, INC.
Rising Funding For Neurological Diagnostics Will Boost Global Neurological Biomarkers Market
The proactive administrative initiatives and rising funding for neurological analysis are likely to drive higher development in this market. For example, the NINDS (National Institute of Neurological Disorders and Stroke) is focused on decreasing the global concerns of neurological diseases by implementing regulatory tactics, evaluating therapeutic & diagnostic methods in neurology, and generating job opportunities for neuroscience research & development.
The global neurological biomarkers market is bifurcated on the basis of application, type, end-use, and regional analysis. Based on the application, the market is divided into Alzheimer’s disease, Parkinson’s disease, autism spectrum disorders, multiple sclerosis, and others. Based on the type, the market is divided into proteomic, genomic, imaging, metabolomic, and others. Based on the end-user, the market is divided into independent clinical diagnostic centers, hospital laboratories, research organizations, and others.
The Asia Pacific Region Expected To Register Massive Growth In The Global Neurological Biomarkers Market
Based on the geographical analysis, the global neurological biomarkers market is divided into Asia Pacific, Europe, North America, Latin America, and Middle East & Africa. The North America region contributed for over 36.5% market share during 2018, due to robust commercial performances of neurological diagnostics across the U.S. Some of the other aspects accounted for the development included proactive administrative initiatives, surge in healthcare spending, and regional presence of major manufacturers. The Asia Pacific region is estimated to witness the fastest development during the forecasted period. The overall improvement in healthcare infrastructure, economic development, a surge in disposable earnings, and a rise in consumer consciousness are projected to contribute to the provincial growth rate.
Request for Custom Research @ https://www.zionmarketresearch.com/custom/3403/news
The global neurological biomarkers market is segmented as follows:
- Multiple Sclerosis
- Alzheimer’s Disease
- Parkinson’s Disease
- Autism Spectrum Disorders
- Research Organizations
- Hospital Laboratories
- Independent Clinical Diagnostic Centers
- North America
- The U.S.
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Make an enquiry of this report @ https://www.zionmarketresearch.com/buynow/su/neurological-iomarkers-market/news
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651